Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled
Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled
10 Pages564 | amjtransplant.com Am J Transplant. 2020;20:564–572. © 2019 The American Society of Transplantation and the American Society of Transplant Surgeons Received: 3 May 2019 | Revised: 25 July 2019 | Accepted: 12 August 2019 DOI: 10.1111/ajt.15580 B RIE F COMMUNIC ATION Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials Bernd Schröppel 1,2 | Enver Akalin 3 | Mukta Baweja 1 | Roy D. Bloom 4 | Sander Florman 5 | Michael Goldstein 5 | Brandy Haydel 5 | Donald E. Hricik 6 | Sanjay Kulkarni 7 | Matthew Levine 8 | Anita Mehrotra 1 | Anup Patel 9 | Emilio D. Poggio 10 | Lloyd Ratner 11 | Ron Shapiro 5 | Peter S. Heeger
